pre-seed
Stage
1
Investors
About
Keyron develops ForePass®, a non-invasive, fully reversible endoscopic device designed to replicate the effects of metabolic surgery for treating severe obesity, type 2 diabetes, NASH, and related conditions without incisions or tissue perforation.
Explore Keyron's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.